A Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular Cancer
Stopped Due to Sorafenib became first line treatment for HCC, the designed treatment became less competitive. The company Sanofi decided not to continue to support
Conditions
- Liver Cancer
- Hepatocellular Cancer
Interventions
- DRUG: Oxaliplatin
- DRUG: Capecitabine
Sponsor
City of Hope Medical Center
Collaborators